Pure red-cell aplasia
MONDO:0001705A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia, and selective erythroid hypoplasia.
Also known as: PRCA, Pure Red Cell Aplasia, Acquired, pure red cell aplasia
33 clinical trials for this condition and its sub-types, 5 tagged with Pure red-cell aplasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Pure red-cell aplasia
-
Diamond-Blackfan anemia 17 trials
22 sub-types
- Diamond-Blackfan anemia 1 1 trial
- Diamond-Blackfan anemia 10 0 trials
- Diamond-Blackfan anemia 11 0 trials
- Diamond-Blackfan anemia 12 0 trials
- Diamond-Blackfan anemia 13 0 trials
- Diamond-Blackfan anemia 14 with mandibulofacial dysostosis 0 trials
- Diamond-Blackfan anemia 15 with mandibulofacial dysostosis 0 trials
- Diamond-Blackfan anemia 16 0 trials
- Diamond-Blackfan anemia 17 0 trials
- Diamond-Blackfan anemia 18 0 trials
- Diamond-Blackfan anemia 19 0 trials
- Diamond-Blackfan anemia 2 0 trials
- Diamond-Blackfan anemia 20 0 trials
- Diamond-Blackfan anemia 21 0 trials
- Diamond-Blackfan anemia 22 0 trials
- Diamond-Blackfan anemia 3 0 trials
- Diamond-Blackfan anemia 4 0 trials
- Diamond-Blackfan anemia 5 0 trials
- Diamond-Blackfan anemia 6 0 trials
- Diamond-Blackfan anemia 7 0 trials
- Diamond-Blackfan anemia 8 0 trials
- Diamond-Blackfan anemia 9 0 trials
-
Adult pure red cell aplasia 2 trials
-
Cheap drug combo may tame tough anemia
Disease control CancelledThis trial tests a combination of two drugs, sirolimus and all-trans retinoic acid (ATRA), for people with autoimmune anemia that has not responded to standard treatments. Autoimmune anemia occurs when the immune system attacks red blood cells, causing fatigue and other symptoms.…
Phase 4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a cancer drug fix blood cell problems after transplant?
Disease control OngoingThis phase 2 trial tests whether isatuximab can help people whose blood cell counts stay low after a stem cell transplant for blood cancer. The study enrolls 12 adults whose disease is in remission but who have developed immune-related blood cell deficiencies. Participants receiv…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Scientists unravel genetic secrets of bone marrow failure
Knowledge-focused By invitation onlyThis study aims to understand the genetic and molecular changes in people with bone marrow failure disorders. Researchers will analyze blood and bone marrow samples from up to 1,400 participants to track how these changes evolve over time. The goal is to better predict disease ou…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC